PharmaCokinetics (PK) / Pharmacodynamics (PD) Studies in Drug Discovery and Development
Watch the Course Now
Watch the Course Now
About the Course
Pharmacokinetics and pharmacodynamics play a critical role in determining whether a drug candidate can progress successfully from discovery into clinical development. Understanding how a compound is absorbed, distributed, metabolized, and excreted, together with its pharmacological response profile, supports informed decisions during lead compound evaluation, toxicological assessment, and human dose projection. PK/PD data also contributes to the interpretation of safety margins, biomarkers, and concentration-response relationships across preclinical studies.
In clinical development, PK/PD assessment is closely tied to dose selection, endpoint evaluation, patient population considerations, and safety monitoring strategies. Inadequate understanding of exposure-effect and time-response relationships can increase development uncertainty and affect study outcomes. This course provides a structured understanding of PK/PD principles and their application in study design, target engagement evaluation, and translational decision-making throughout drug discovery and development programs.
Key Areas Covered
Quality training, expert insights, and answers that matter. Know your Expert
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Access course materials
4. Watch The Streaming and Complete your Course


